Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function.
Fishwild, D M
Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function. [electronic resource] - The Journal of rheumatology Apr 1994 - 596-604 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
0315-162X
Adult
Antibodies, Monoclonal--therapeutic use
Antigens, CD
Arthritis, Rheumatoid--blood
B-Lymphocyte Subsets--drug effects
CD5 Antigens
Cytotoxicity, Immunologic--drug effects
Female
Humans
Immunoglobulin G--therapeutic use
Immunotoxins--therapeutic use
In Vitro Techniques
Leukocyte Count
Male
Middle Aged
Phenotype
Receptors, IgG--metabolism
Ricin--therapeutic use
T-Lymphocyte Subsets--drug effects
Administration of an anti-CD5 immunoconjugate to patients with rheumatoid arthritis: effect on peripheral blood mononuclear cells and in vitro immune function. [electronic resource] - The Journal of rheumatology Apr 1994 - 596-604 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
0315-162X
Adult
Antibodies, Monoclonal--therapeutic use
Antigens, CD
Arthritis, Rheumatoid--blood
B-Lymphocyte Subsets--drug effects
CD5 Antigens
Cytotoxicity, Immunologic--drug effects
Female
Humans
Immunoglobulin G--therapeutic use
Immunotoxins--therapeutic use
In Vitro Techniques
Leukocyte Count
Male
Middle Aged
Phenotype
Receptors, IgG--metabolism
Ricin--therapeutic use
T-Lymphocyte Subsets--drug effects